Master data| INID | Criterion | Field | Content |
|---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
| 21 | DE file number | DAKZ | 60 2004 050 333.9 |
| 96 | EP file number | EAKZ | 10 01 1901.5 |
| 97 | EP publication number | EPN | 2281577 |
| 54 | Designation/title | TI | Arzneimittel-Konjugat-Zusammensetzung |
| 51 | IPC main class | ICM
(ICMV) | A61K 47/50 (2017.01) |
| 22 | DE application date | DAT | May 14, 2004 |
| 96 | EP application date | EAT | May 14, 2004 |
| 43 | Date of first publication | OT | Feb 9, 2011 |
| Date of publication of grant | PET | Nov 16, 2016 |
| 71/73 | Applicant/owner | INH | ImmunoGen, Inc., Waltham, Mass., US |
| 72 | Inventor | IN | Amphlett, Godfrey, CambridgeMA 02138, US; Zhang, Wei, Wayne, PA 19087, US; Fleming, Michael, LondonderryNH 03053, US; Chih, Hung-Wei, CambridgeMA 02139, US |
| Address for service | | Immunogen, Inc., WALTHAM, MA. 02451, US |
33
31
32
| Foreign priority | PRC
PRNA
PRDA
| US
470550 P
May 14, 2003
|
| Patent division in charge | | 44 |
| 97 | EP language of publication | ELANG | EN - Englisch |
| 84 | Designated EP contracting states | EDS | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000002281577
Searchable text:
EP000002281577
Original document:
EP000002281577B1
Searchable text:
EP000002281577B1 |
| 43 | Date of first publication | EVT | Feb 9, 2011 |
| Date of the first transfer into DPMAregister | EREGT | May 27, 2011 |
| Date of the (most recent) update in DPMAregister | REGT | Aug 19, 2019
(Show all update days)(Hide all update days)- Aug 19, 2019; Jul 11, 2019; Feb 1, 2018; Jan 17, 2018; Nov 9, 2017; Oct 26, 2017; Jun 9, 2017; Dec 29, 2016; Nov 19, 2016; Nov 17, 2016; Jun 2, 2016; May 29, 2015; Feb 15, 2013; Oct 6, 2011
- Historical data not available for this/these date(s)
- May 27, 2011
- Date of the first transfer into DPMAregister
|
